NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Reserve excluding Revaluation Reserve History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Reserve excluding Revaluation Reserve | ₹279 Cr | ₹260 Cr | ₹219 Cr | ₹200 Cr | ₹151 Cr |
What is the latest Reserve excluding Revaluation Reserve ratio of NGL FINECHEM ?
| Year | Reserve excluding Revaluation Reserve |
|---|---|
| Mar2025 | ₹279 Cr |
| Mar2024 | ₹260 Cr |
| Mar2023 | ₹219 Cr |
| Mar2022 | ₹200 Cr |
| Mar2021 | ₹151 Cr |
How is Reserve excluding Revaluation Reserve of NGL FINECHEM Trending?
| Years | Reserve excluding Revaluation Reserve | % Change | |
|---|---|---|---|
| Mar2025 | ₹279 Cr | 7.63 | |
| Mar2024 | ₹260 Cr | 18.26 | |
| Mar2023 | ₹219 Cr | 9.66 | |
| Mar2022 | ₹200 Cr | 32.21 | |
| Mar2021 | ₹151 Cr | - | |
Compare Reserve excluding Revaluation Reserve of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,497.4 Cr | 6.9% | 3.8% | 98.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,195.0 Cr | 0.9% | 12.7% | 8.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,993.0 Cr | -0.4% | 9.7% | 11.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,926.0 Cr | 0.5% | 5.8% | 36.5% | Stock Analytics | |
| CIPLA | ₹113,052.0 Cr | -2.7% | 13.9% | -6.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,333.0 Cr | 1.5% | 7.3% | 8% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 6.9% |
3.8% |
98.8% |
| SENSEX | 1% |
-4.1% |
-7.4% |
You may also like the below Video Courses